KnowWhatYouHold
@KnowWhatYouHold
Followers
438
Following
569
Media
31
Statuses
473
Long Island, New York
Joined August 2020
Huge potential here. Majorly de-risked. It's only a matter of time for approval. $NWBO
Here is the math just for estimated annual #DCVax revenue for $NWBO just for the UK & the rest of the EU, at initial scale-up using Flaskworks to 1,000 patients per month: $2.4 billion per year. This does not include the US & Canada:
0
4
32
Yes. KNOW WHAT YOU HOLD. Nick @KnowWhatYouHold made this website 4 years ago and a lot of information here is still KEY KNOWLEDGE even though it was last updated during 2022. https://t.co/0UX7stNvYy I get the frustration. But I also know the history. IN DETAIL.
knowwhatyouhold.com
Perform your DD, and know what you hold.
1
1
6
Hello everyone, My name is Thomas, Today is a special day for me. Today marks the ten year anniversary of my diagnosis of a Glioblastoma Multiforme Marker 4. It’s been a rough ride with some moments of pure happiness. I’ve met some amazing friends, & lost some great ones. I got
39
49
246
$NWBO Excellent dissection by @hoffmann6383 of Adam Feuersteins decade year long lie regarding NWBO being unblinded. Maybe Laura Posner can use this in a future trial against some of the lower ranked forces, who have worked in cahoot with hedges or/and market makers?
📰Adam Feuerstein: When the facts refute your claim of failure, make up your own 📰 @adamfeuerstein $NWBO #JPM25 In this post I do a quick review of Mr. Feuerstein’s tweets and articles since 2019. Specifically, I look at why Mr. Feuerstein states as fact that $NWBO’s #DCVax-L
1
6
48
🟩STAT, is one of your columnists, Adam Feuerstein, colluding with hedge funds?⁉️ ➡️In this post I'll do a cursory review of Mr. Feuerstein's possible collusive activities with hedge funds that are purportedly engaged in illegal share price manipulation. A May 2, 2016 article
20
55
166
Thank you to our #GBMDay sponsors. Because of your generous support, we are able to shine a light on the urgent, unmet needs of the #glioblastoma (#GBM) community: https://t.co/T2XEwjPSqr
0
16
72
Anyone bashing this treatment is the definition of evil.
"We must now do everything we can to ensure this long-awaited hope is able to reach patients as soon as possible, at a price the NHS can afford. Stay tuned for more updates." @BrainTumourOrg #DCVax-L #GreyMay 1. https://t.co/Qqd3JC8244 2. https://t.co/2P6V3vM60n $NWBO
0
0
13
Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and results was quite the accomplishment. 1. https://t.co/kj90HJAi3f 2. https://t.co/pfRDJT4azX $NWBO
2
17
75
$NWBO A couple of the hired moderators on Ihub in the pocket of fraudulent forces, don't like when their fellow fraudsters are called out, even when done so eloquently mild as @ATLnsider does here. Please do retweet 🙏🏻
Unfortunately, IHub keeps removing this post I made today about $NWBO and #DCVax. So, I am posting it here to preserve it:
0
10
48
$NWBO perhaps one of the last times to buy in the .60s. Scooped up a few thousand more. UK submission and approval coming in the next few months.
0
0
25
Advent Bioservices MIA has been published by the MHRA. Authorization date: 20/03/2023 $NWBO #DCVax-L https://t.co/JUt2L0rD9J
1
26
122
This analysis was from July 19, 2022 (still applies IMO). 1. #DCVax-L for ndGBM + rGBM indications (highly) possibly covered in MAA / BLA filings. Both were mentioned on the JAMA publication, presentations, and clinical trial records. 2. $NWBO has sufficient cash through 2023.
2
17
60
Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cell vaccine trial, led by Dr. Linda Liau, as one of the "Best Advances of 2022." #immunotherapy @PennNeurology @PennNSG @PennCancer
https://t.co/U8ML7OCOBR
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov Identifier: NCT00045968.
4
46
160
$NWBO #DCVax-L trial results picked by the editorial board as 1 of the top / best advances - “News That Mattered”- during 2022 in the 1/19/2023 edition of Neurology Today: https://t.co/bXdj99sR08
3
43
155
“It’s already underhanded to engage in #marketmanipulation, but to do so at the expense of cancer patients, some of whom have no other treatments to place their hopes on, is unconscionable,” said Laura Posner at Cohen Milstein. #spoofing
https://t.co/BRe8bQlK8W via @WSJ
wsj.com
In a new lawsuit, Northwest Biotherapeutics accused market makers of illicit “spoofing” orders.
34
149
385
#New: The Lifespan Cancer Institute will release the results of a vaccine trial for aggressive brain cancer.
abc6.com
PROVIDENCE, R.I. (WLNE) — The Lifespan Cancer Institute on Friday released the results of a vaccine trial for aggressive brain cancer. Lifespan said that a Phase III clinical trial of the DCVax-L...
3
29
129
@biosectinvestor For those who prefer a visualization of the NICE #DCVax-L status changes before the error, during the error, and after the correction as of date, see below. Status: Topic selection Decision: Awaiting decision $NWBO https://t.co/k6HQ28nqab
4
16
73
Worst biotechnology writer of the year award goes to @adamfeurerstein and @statnews ! Congratulations to you all!
Since it appears to be award season, here is an award for worst biotech writer. When he is not Twitter warring with neurosurgeons or lying about clinical trials, our esteemed recipient just stands around looking clueless. Congratulations to @statnews smear on society, AF! $NWBO
0
1
4